Stay informed with the latest litigation news. Explore now

IP Verse

Allergan competitive analysis

Latest publications and patents of Allergan New

Explore the latest publications and patents granted to Allergan, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Allergan
EP2442821	Feb 12, 2025	Safe Desmopressin Administration	Patent Maintained As Amended
EP3509559	Jul 19, 2023	Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing Thereof	Granted And Under Opposition
EP2877138	Jun 28, 2023	Dual Cap System For Container-Closures To Maintain Tip Sterility During Shelf Storage	Granted And Under Opposition
EP2381923	Jun 7, 2023	Safe Desmopressin Administration	Patent Maintained As Amended
EP3024479	Feb 8, 2023	High Potency Pancreatin Pharmaceutical Compositions	Patent Maintained As Amended
EP3436054	Jul 27, 2022	Stabilized Non-Protein Clostridial Toxin Compositions	Patent Maintained As Amended
EP3520827	May 25, 2022	Cross-Linked Hydrogels For Soft Tissue Augmentation	Revoked
EP3681500	Mar 23, 2022	Use Of Pilocarpine Hydrochloride For The Treatment Of Ocular Conditions	Granted And Under Opposition
EP3431074	Jan 19, 2022	Preservative Free Bimatoprost And Timolol Solutions	Granted And Under Opposition
EP3256097	Jan 5, 2022	Compositions And Methods For Improving Skin Appearance	Granted And Under Opposition

Latest oppositions filed by Allergan

Explore patent oppositions filed by Allergan against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3236939	Botulinum Toxin Prefilled Container	MERZ PHARMA	Dec 31, 2020
EP3233043	Process For Preparing Hydrogels	TEOXANE	Aug 5, 2020
EP3274685	Process For Evaluating The Mechanical Performance Of A Filler Gel	TEOXANE	Jul 2, 2020
EP3027186	Composition Comprising Hyaluronic Acid And Mepivacaine	TEOXANE	Mar 18, 2020
EP2912074	Dermal Injectable Sterile Composition	TEOXANE	Feb 3, 2020
EP2939688	Pharmaceutical Compositions Comprising Botulinum Neurotoxin	IPSEN BIOPHARM	Nov 20, 2019
EP3250185	Ophthalmic Suspension Composition	BAUSCH & LOMB INCORPORATED	Sep 4, 2019
EP2627318	Formulation Suitable For Stabilizing Proteins, Which Is Free Of Mammalian Excipients	MERZ PHARMA	May 16, 2018
EP2661276	Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin Compositions	REVANCE THERAPEUTICS	May 2, 2018
EP2800811	Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription	CHARPENTIER	Feb 11, 2018

Latest patents of Allergan opposed by its competitors

Explore Allergan's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP2442821	Feb 12, 2025	Safe Desmopressin Administration	1
EP3509559	Jul 19, 2023	Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing Thereof	1
EP2877138	Jun 28, 2023	Dual Cap System For Container-Closures To Maintain Tip Sterility During Shelf Storage	1
EP2381923	Jun 7, 2023	Safe Desmopressin Administration	1
EP3024479	Feb 8, 2023	High Potency Pancreatin Pharmaceutical Compositions	1
EP3436054	Jul 27, 2022	Stabilized Non-Protein Clostridial Toxin Compositions	1
EP3520827	May 25, 2022	Cross-Linked Hydrogels For Soft Tissue Augmentation	1
EP3681500	Mar 23, 2022	Use Of Pilocarpine Hydrochloride For The Treatment Of Ocular Conditions	1
EP3431074	Jan 19, 2022	Preservative Free Bimatoprost And Timolol Solutions	6
EP3256097	Jan 5, 2022	Compositions And Methods For Improving Skin Appearance	2

Latest PTAB cases involving Allergan New

Discover the latest PTAB cases involving Allergan, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 15, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Allergan
PGR2021-00024	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Terminated-Settled
PGR2021-00023	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Terminated-Settled
PGR2021-00022	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Terminated-Settled
PGR2021-00021	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Institution Denied
PGR2021-00020	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Institution Denied
PGR2021-00018	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Institution Denied
PGR2021-00017	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Institution Denied
PGR2021-00016	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Institution Denied
PGR2021-00015	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Institution Denied
PGR2021-00025	Dec 14, 2020	ALLERGAN	BTL MEDICAL SRO	Terminated-Settled

Top competitors of Allergan

Top competitors of Allergan based on patent oppositions.

MERZ PHARMA

LABORATOIRES VIVACY

TEOXANE